Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rixe

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Bulletin Du Cancer|November 28, 2008
[Edifice program: analysis of screening exam practices for cancer in France]J-Y Blay, F Eisinger, O Rixe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patientsY Bécouarn, E Gamelin, B Coudert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinibB Beuselinck, S Oudard, O Rixe, et al.
Cancer Biomarkers : Section a of Disease Markers|May 27, 2008
Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic valueA Tadlaoui Hbibi, C Lagorce, P Wind, et al.
Seminars in Oncology|December 1, 1996
Phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma: preliminary resultsD Coeffic, A Benhammouda, E C Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2010
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC NetworkG G Malouf, P Camparo, S Oudard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
British Journal of Cancer|July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II studyA Roy, D Cunningham, R Hawkins, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Bulletin Du Cancer|November 28, 2008
[Edifice program: analysis of screening exam practices for cancer in France]J-Y Blay, F Eisinger, O Rixe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patientsY Bécouarn, E Gamelin, B Coudert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinibB Beuselinck, S Oudard, O Rixe, et al.
Cancer Biomarkers : Section a of Disease Markers|May 27, 2008
Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic valueA Tadlaoui Hbibi, C Lagorce, P Wind, et al.
Seminars in Oncology|December 1, 1996
Phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma: preliminary resultsD Coeffic, A Benhammouda, E C Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2010
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC NetworkG G Malouf, P Camparo, S Oudard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
British Journal of Cancer|July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II studyA Roy, D Cunningham, R Hawkins, et al.
Pageof 7